Calida Therapeutics operates as a biotechnology company.
Calida Therapeutics has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Calida Therapeutics's investors include AdBio partners.
Calida Therapeutics is headquartered in Paris, France.
Calida Therapeutics operates as a biotechnology company.
Calida Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calida Therapeutics — Funding & Investors." VCBacked, April 6, 2023, https://www.vcbacked.co/company/calida-therapeutics. Accessed October 27, 2026.
VCBacked. (2023). Calida Therapeutics — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/calida-therapeutics
{{cite web |title=Calida Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/calida-therapeutics |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated